1. Home
  2. UGRO vs ARTL Comparison

UGRO vs ARTL Comparison

Compare UGRO & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UGRO
  • ARTL
  • Stock Information
  • Founded
  • UGRO 2014
  • ARTL 2011
  • Country
  • UGRO United States
  • ARTL United States
  • Employees
  • UGRO N/A
  • ARTL N/A
  • Industry
  • UGRO Industrial Specialties
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • UGRO Consumer Discretionary
  • ARTL Health Care
  • Exchange
  • UGRO Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • UGRO 3.8M
  • ARTL 3.1M
  • IPO Year
  • UGRO N/A
  • ARTL N/A
  • Fundamental
  • Price
  • UGRO $0.32
  • ARTL $23.88
  • Analyst Decision
  • UGRO Strong Buy
  • ARTL Strong Buy
  • Analyst Count
  • UGRO 1
  • ARTL 2
  • Target Price
  • UGRO $3.00
  • ARTL $25.00
  • AVG Volume (30 Days)
  • UGRO 538.3K
  • ARTL 1.9M
  • Earning Date
  • UGRO 07-22-2025
  • ARTL 08-12-2025
  • Dividend Yield
  • UGRO N/A
  • ARTL N/A
  • EPS Growth
  • UGRO N/A
  • ARTL N/A
  • EPS
  • UGRO N/A
  • ARTL N/A
  • Revenue
  • UGRO $59,985,138.00
  • ARTL N/A
  • Revenue This Year
  • UGRO N/A
  • ARTL N/A
  • Revenue Next Year
  • UGRO $31.25
  • ARTL N/A
  • P/E Ratio
  • UGRO N/A
  • ARTL N/A
  • Revenue Growth
  • UGRO N/A
  • ARTL N/A
  • 52 Week Low
  • UGRO $0.26
  • ARTL $4.92
  • 52 Week High
  • UGRO $1.92
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • UGRO 55.26
  • ARTL 72.07
  • Support Level
  • UGRO $0.29
  • ARTL $9.11
  • Resistance Level
  • UGRO $0.34
  • ARTL $28.60
  • Average True Range (ATR)
  • UGRO 0.04
  • ARTL 4.19
  • MACD
  • UGRO 0.01
  • ARTL 1.92
  • Stochastic Oscillator
  • UGRO 49.04
  • ARTL 79.31

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: